Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuximab).
De Luca R, Lo Coco G, Addeo R, Fattoruso SIS, Auriemma A, Paci R, Mistretta O, Epifanio MS, Salvato A, D'Agostino A, Cicero G. De Luca R, et al. Among authors: auriemma a. World J Oncol. 2021 Aug;12(4):104-110. doi: 10.14740/wjon1381. Epub 2021 Jul 10. World J Oncol. 2021. PMID: 34349854 Free PMC article.
Clinical activity of regorafenib in elderly patients with recurrent glioblastoma.
Fasano M, Pirozzi M, Famiglietti V, Facchini S, Caterino M, Caroprese M, Barillaro A, Di Giovanni I, Auriemma A, Ileana Sara Fattoruso S, Somma T, Solari D, Bocchetti M, Conson M, Pacelli R, Ciardiello F, Addeo R. Fasano M, et al. Among authors: auriemma a. Mol Clin Oncol. 2023 Jan 10;18(2):9. doi: 10.3892/mco.2023.2605. eCollection 2023 Feb. Mol Clin Oncol. 2023. PMID: 36761386 Free PMC article.
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO).
Speranza D, Sapuppo E, Aprile G, Auriemma A, Bergamo F, Bianco R, Bordonaro R, Brandi G, Brunetti O, Carnaghi C, Ciliberto D, Cinieri S, Corallo S, De Vita F, Di Donato S, Ferraù F, Fornaro L, Barucca V, Giommoni E, Lotesoriere C, Luchini C, Masini C, Niger M, Pisconti S, Rapposelli IG, Rimassa L, Rognone C, Rodriquenz MG, Corsini LR, Santin D, Scarpa A, Scartozzi M, Soto Parra H, Tonini G, Tortora G, Tralongo P, Silvestris N. Speranza D, et al. Among authors: auriemma a. Tumori. 2024 Feb 7:3008916231222761. doi: 10.1177/03008916231222761. Online ahead of print. Tumori. 2024. PMID: 38326240
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode.
Avancini A, Borsati A, Baldo E, Ciurnelli C, Trestini I, Tregnago D, Belluomini L, Sposito M, Insolda J, Auriemma A, Fiorio E, Piacentini M, Schena F, Milella M, Pilotto S. Avancini A, et al. Among authors: auriemma a. Oncologist. 2024 Jan 11:oyae002. doi: 10.1093/oncolo/oyae002. Online ahead of print. Oncologist. 2024. PMID: 38206849 Free article.
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients.
Dalbeni A, Natola LA, Garbin M, Zoncapè M, Cattazzo F, Mantovani A, Vella A, Canè S, Kassem J, Bevilacqua M, Conci S, Campagnaro T, Ruzzenente A, Auriemma A, Drudi A, Zanoni G, Guglielmi A, Milella M, Sacerdoti D. Dalbeni A, et al. Among authors: auriemma a. Cancers (Basel). 2023 Apr 22;15(9):2406. doi: 10.3390/cancers15092406. Cancers (Basel). 2023. PMID: 37173873 Free PMC article.
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma.
Trestini I, Carbognin L, Peretti U, Sperduti I, Caldart A, Tregnago D, Avancini A, Auriemma A, Orsi G, Pilotto S, Frulloni L, Capurso G, Bria E, Reni M, Tortora G, Milella M. Trestini I, et al. Among authors: auriemma a. Front Oncol. 2021 Sep 9;11:688889. doi: 10.3389/fonc.2021.688889. eCollection 2021. Front Oncol. 2021. PMID: 34568019 Free PMC article.
Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study.
Bordonaro R, Calvo A, Auriemma A, Hollebecque A, Rubovszky G, Saunders MP, Pápai Z, Prager G, Stein A, André T, Argilés G, Cubillo A, Dahan L, Edeline J, Leger C, Cattan V, Fougeray R, Amellal N, Tabernero J. Bordonaro R, et al. Among authors: auriemma a. ESMO Open. 2021 Oct;6(5):100270. doi: 10.1016/j.esmoop.2021.100270. Epub 2021 Sep 20. ESMO Open. 2021. PMID: 34547581 Free PMC article. Clinical Trial.
57 results